Treats Parkinson's disease. ANDA 203354, held by Dr. Reddy's Laboratories. Pramipexole Dihydrochloride.
As of Nov 21, 2026, ANDA 203354 (Pramipexole Dihydrochloride), held by Dr. Reddy's Laboratories, was first approved by FDA on Aug 7, 2015, with 6 approved supplements and 0 published complete response letters.
Pramipexole dihydrochloride extended-release tablets are indicated for the treatment of Parkinson's disease. Pramipexole dihydrochloride extended-release tablet is a non-ergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD)
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 7, 2015 | Original application | Approved | None posted |
| Pramipexole Dihydrochloride0.375MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride0.75MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride1.5MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride3MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride4.5MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Rx |
| Feb 25, 2025 | Supplement 8Labeling · Standard review | Approved | None posted |
| Feb 25, 2025 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 14, 2020 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 14, 2020 | Supplement 5Labeling · Standard review | Approved | None posted |
| Oct 14, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 7, 2015 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters